Experiment 492351
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV INFUSION |
| Organism | Empty organism |
| Citation | SLAYTON,R: BLESSING,J: ANGEL,C: BERMAN,M:. (1987). PHASE II TRIAL OF ETOPOSIDE IN THE MANAGEMENT OF ADVANCED AND RECURRENT LEIOMYOSARCOMA OF THE UTERUS: A GYNECOLOGIC ONCOLOGY GROUP STUDY.. 71(12) |
| Amount utilized | |
| Compound isolated | |
| Disease | IN A SERIES OF PHASE II TRIAL DESIGNED TO TEST AGENTS IN GYNECOLOGIC MALIGNANCIES,28 PATIENTS WERE ACCRUED. ONE COMPLETE RESPONSE LASTING 2.5 MONTHS AND 2 PARTIAL RESPONSES LASTING 2 AND 4.5 MONTHS WERE NOTED; TEN PATIENTS HAD STABLE DISEASES WHILE 15 HAD INCREASING DISEASE. THE OBSERVED RESPONSE RATE WAS 10.7%. |
| Dose amount | 100.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | SQ M |
| Dose expression | DOSE |